Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance.
- NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_assertion description "[The rationale of ?1-antitrypsin (AAT) augmentation therapy to treat progressive emphysema in AAT-deficient patients is based on inhibition of neutrophil elastase; however, the benefit of this treatment remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance.
- NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_assertion evidence source_evidence_literature NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance.
- NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_assertion SIO_000772 23975926 NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance.
- NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_assertion wasDerivedFrom befree-2016 NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance.
- NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_assertion wasGeneratedBy ECO_0000203 NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1105282.RAzxPw567qp4rFkcm2lGG4jeVSSC5dXJq28vSgN-UYPr0130_provenance.